Morgan Stanley analyst Gaurav Rateria upgraded MakeMyTrip to Overweight from Equal Weight with an unchanged price target of $36. Rateria sees an entry point with the stock having underperformed in the last three months, arguing that the strong recovery in travel and MakeMyTrip’s resilient margins make the risk-reward favorable.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MMYT:
